Release 5

This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Example MedicationDispense/meddisp0317 (Narrative)

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Encounter, Patient, Practitioner

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationDispense.

Generated Narrative: MedicationDispense

Resource MedicationDispense "meddisp0317"

status: stopped

Medications

-Reference
*

code: Adcetris (Brentuximab Vedotin 50mg/10.5ml) (National drug codes#51144-050-01)

marketingAuthorizationHolder: Organization/mmanu "Acme Corporation"

doseForm: Lyophilized powder for injectable solution (qualifier value) (SNOMED CT#421637006)

subject: Patient/pat1: Donald Duck "Donald DUCK"

Performers

-Actor
*Practitioner/f006 "Rob VAN DEN BERK"

authorizingPrescription: MedicationRequest/medrx0316

type: Trial Fill (ActCode#TF)

quantity: 3(unit 415818005 from http://snomed.info/sct) (Details: SNOMED CT code 415818005 = '415818005')

daysSupply: 1 Day (Details: UCUM code d = 'd')

whenPrepared: 2015-06-25T07:13:00+05:00

whenHandedOver: 2015-06-26T07:13:00+05:00

dosageInstruction

sequence: 1

text: 1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles

timing: Count 16 times, Once per 3 weeks

route: Intravenous (SNOMED CT#255560000)

doseAndRate

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.